Jan 24, 2023 | Corporate News
Telligen employee-owners Brianna Gass, MPH, Jane Brock, MD, MSPH, Christine LaRocca, MD and Lacey McFall, MA, MPH are co-authors on a research article published in “Healthcare: The Journal of Delivery Science and Innovation.” The article, “Perspectives of...
Jan 17, 2023 | Corporate News
Telligen is excited to announce its fourth update on enhancements made to Qualitrac in 2022. Our clinical and technical experts work year-round to enhance and advance the product, which is how we’re able to help our clients achieve their goals for quality and outcomes...
Dec 27, 2022 | Corporate News
WEST DES MOINES, IA – Telligen is excited to announce its formal Mentor-Protégé with ATW Health Solutions, a woman-owned small business (WOSB) human-centered quality improvement healthcare advisory firm based in Chicago. Under the agreement, ATW Health Solutions will...
Dec 1, 2022 | Corporate News
Telligen is excited to announce its third update on enhancements made to Qualitrac in 2022. Our clinical and technical experts work year-round to enhance and advance the product, which is how we’re able to help our clients achieve their goals for quality and outcomes...
Nov 30, 2022 | Corporate News
Telligen, as part of CodeX and in partnership with multiple leading oncology professional societies, clinical leaders, payers and other partners, introduced their CodeX Quality Measures for Cancer use case to more than 100 CodeX stakeholders from various...
Nov 8, 2022 | Corporate News, Employers & Health Plans
Diabetes is a serious disease. According to the CDC (Centers for Disease Control), more than 37 million people in the United States have diabetes, and it is the 7th leading cause of death in the United States. Diabetes causes more deaths per year than breast cancer...
